EUVIMEDEUVIMED entdecken
Multizentrische Studie

Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritis

Clément Samoreau, Giorgina Barbara Piccoli, Cécile Martin, Philippe Gatault, Emeline Vinatier, Frank Bridoux, Jérémie Riou, Alice Desouche, Pierre Jourdain, Jean-Philippe Coindre, Samuel Wacrenier, Fanny Guibert und 10 weitere

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfac240 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Clément Samoreau und 21 weiteren Autor:innen. Beteiligte Einrichtung: Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Glomerulonephritis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anti-neutrophil cytoplasmic antibody (ANCA) kinetic in ANCA-associated vasculitis with glomerulonephritis (AAV-GN) has been suggested to be associated with AAV relapse. Few studies have focused on its association with renal prognosis. Thus we aimed to investigate the relationship between ANCA specificity and the evolutive profile and renal outcomes.

Methods

This multicentric retrospective study included patients diagnosed with ANCA-GN since 1 January 2000. Patients without ANCA at diagnosis and with fewer than three ANCA determinations during follow-up were excluded. We analysed estimated glomerular filtration rate (eGFR) variation, renal-free survival and relapse-free survival according to three ANCA profiles (negative, recurrent and persistent) and to ANCA specificity [myeloperoxidase (MPO) or proteinase 3 (PR3)].

Results

Over a follow-up of 56 months [interquartile range (IQR) 34–101], a median of 19 (IQR 13–25) ANCA determinations were performed for the 134 included patients. Patients with a recurrent/persistent ANCA profile had a lower relapse-free survival (P = .019) and tended to have a lower renal survival (P = .053) compared with those with a negative ANCA profile. Patients with a recurrent/persistent MPO-ANCA profile had the shortest renal survival (P = .015) and those with a recurrent/persistent PR3-ANCA profile had the worst relapse-free survival (P = .013) compared with other profiles. The negative ANCA profile was associated with a greater eGFR recovery. In multivariate regression analysis, it was an independent predictor of a 2-fold increase in eGFR at 2 years [odds ratio 6.79 (95% confidence interval 1.78–31.4), P = .008]).

Conclusion

ANCA kinetic after an ANCA-GN diagnosis is associated with outcomes. MPO-ANCA recurrence/persistence identifies patients with a lower potential of renal recovery and a higher risk of kidney failure, while PR3-ANCA recurrence/persistence identifies patients with a greater relapse risk. Thus ANCA kinetics may help identify patients with a smouldering disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGlomerulonephritisHumansAntibodies, Antineutrophil CytoplasmicRetrospective StudiesKidneyChronic DiseaseMyeloblastinPeroxidase

Stichwörter der Autor:innen

AAVANCAglomerulonephritiskidney failurerenal prognosis

Substanzen

Antibodies, Antineutrophil CytoplasmicMyeloblastinPeroxidase

Autor:innen und Institutionen

  • Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France.
  • Service de Néphrologie-Dialyse, Centre Hospitalier du Mans, Le Mans, France.
  • Service de Néphrologie-Dialyse-Transplantation, CHU de Poitiers, Poitiers, France.
  • Service de Néphrologie-Dialyse-Transplantation, CHU de Tours, Tours, France.
  • Laboratoire d'Immunologie et Allergologie, CHU Angers, Angers, France.
  • Université d'Angers, Inserm, CNRS, Nantes Université, CRCI2NA, Angers, France.

ORCID-Profile: Odile Blanchet, Jean-François Augusto, Benoit Brilland

Zitieren

APA

Samoreau, C., Piccoli, G. B., Martin, C., Gatault, P., Vinatier, E., Bridoux, F., Riou, J., Desouche, A., Jourdain, P., Coindre, J. P., Wacrenier, S., Guibert, F., Henry, N., Blanchet, O., Croué, A., Djema, A., Pouteau, L. M., Copin, M. C., Beauvillain, C., …, & Brilland, B. (2023). Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritis. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac240

Vancouver

Samoreau C, Piccoli GB, Martin C, Gatault P, Vinatier E, Bridoux F, et al. Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritis. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfac240

BibTeX
@article{Samoreau2023,
  author = {Samoreau, Clément and Piccoli, Giorgina Barbara and Martin, Cécile and Gatault, Philippe and Vinatier, Emeline and Bridoux, Frank and Riou, Jérémie and Desouche, Alice and Jourdain, Pierre and Coindre, Jean-Philippe and Wacrenier, Samuel and Guibert, Fanny and Henry, Nicolas and Blanchet, Odile and Croué, Anne and Djema, Assia and Pouteau, Lise-Marie and Copin, Marie-Christine and Beauvillain, Céline and Subra, Jean-François and Augusto, Jean-François and Brilland, Benoit},
  title = {Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritis},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfac240}
}
Kostenlos starten →